This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Akbari, M. Articles by Krokan, H. E. Search for Related Content PubMed PubMed Citation Articles by Akbari, M. Articles by Krokan, H. E.

JMD 2005, Vol. 7, No. 1
Copyright © 2005 American Society for Investigative Pathology & Association for Molecular Pathology

Low Copy Number DNA Template Can Render Polymerase Chain Reaction Error Prone in a Sequence-Dependent Manner

Mansour Akbari^*, Marianne Doré Hansen^*, Jostein Halgunset, Frank Skorpen^* and Hans E. Krokan^*

From the Department of Cancer Research and Molecular Medicine * and the Department of Laboratory Medicine, Children’s and Women’s Health, Norwegian University of Science and Technology, Trondheim, Norway

Paraffin-embedded tissue is an important source of material for molecular pathology and genetic investigations. We used DNA isolated from microdissected formalin-fixed, paraffin-embedded gastric tumors for mutation analysis of a region of the human gene for uracil-DNA glycosylase (UNG), encoding the UNG catalytic domain, and detected apparent base substitutions which, after further investigation, proved to be polymerase chain reaction (PCR) artifacts. We demonstrate that low DNA template input in PCR can generate false mutations, mainly guanine to adenine transitions, in a sequence-dependent manner. One such mutation is identical to a mutation previously reported in the UNG gene in human glioma. This phenomenon was not caused by microheterogeneity in the sample material because the same artifact was seen after amplification of a homogenous, diluted plasmid. We did not observe genuine mutations in the UNG gene in 16 samples. Our results demonstrate that caution should be taken when interpreting data from PCR-based analysis of somatic mutations using low amounts of template DNA, and that methods used to enrich putative subpopulations of mutant molecules in a sample material could, in essence, be a further amplification of sequence-dependent PCR-generated artifacts.

This article has been cited by other articles:

				D. A. Eberhard, G. Giaccone, and B. E. Johnson Biomarkers of Response to Epidermal Growth Factor Receptor Inhibitors in Non-Small-Cell Lung Cancer Working Group: Standardization for Use in the Clinical Trial Setting J. Clin. Oncol., February 20, 2008; 26(6): 983 - 994. [Abstract] [Full Text] [PDF]

				L. V. Sequist, V. A. Joshi, P. A. Janne, D. W. Bell, P. Fidias, N. I. Lindeman, D. N. Louis, J. C. Lee, E. J. Mark, J. Longtine, et al. Epidermal growth factor receptor mutation testing in the care of lung cancer patients. Clin. Cancer Res., July 15, 2006; 12(14): 4403s - 4408s. [Abstract] [Full Text] [PDF]

				R. Y. Lai, E. T. Lagally, S.-H. Lee, H. T. Soh, K. W. Plaxco, and A. J. Heeger Rapid, sequence-specific detection of unpurified PCR amplicons via a reusable, electrochemical sensor. PNAS, March 14, 2006; 103(11): 4017 - 4021. [Abstract] [Full Text] [PDF]

				R. E. Banks, P. Tirukonda, C. Taylor, N. Hornigold, D. Astuti, D. Cohen, E. R. Maher, A. J. Stanley, P. Harnden, A. Joyce, et al. Genetic and Epigenetic Analysis of von Hippel-Lindau (VHL) Gene Alterations and Relationship with Clinical Variables in Sporadic Renal Cancer Cancer Res., February 15, 2006; 66(4): 2000 - 2011. [Abstract] [Full Text] [PDF]

				A. Marchetti, L. Felicioni, F. Buttitta, M.-S. Tsao, S. Kamel-Reid, and F. A. Shepherd Assessing EGFR Mutations N. Engl. J. Med., February 2, 2006; 354(5): 526 - 528. [Full Text] [PDF]